BOLD
Boundless Bio, Inc.
2.60$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.1% | +6.5% | +0.8% | -1.1% | +13.0% | +7.1% | +0.0% | -2.2% | -1.0% | -7.5% | +342.6% | – | |
| – | +3.2% | +45.8% | +60.8% | -4.2% | -1.8% | -10.5% | -5.8% | -23.0% | +2.2% | +2.9% | +235.0% | – | |
| – | -133.1% | – | – | – | -169.6% | – | – | +7.9% | -55.0% | -529.4% | – | – | |
| – | +77.5% | -69.0% | +1,712.0% | -67.9% | -3.5% | -87.3% | -18.6% | -68.8% | +2,726.7% | -98.1% | +375.0% | – | |
| – | – | +14.7% | -476.0% | – | -91.8% | +67.9% | +269.0% | -7.2% | +23.8% | +12.5% | +58.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +209.6% | -33.2% | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | – | |
| – | – | -47.6% | +332.8% | +42.3% | -254.0% | – | – | – | +920.5% | -113.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.